Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Clinical trial NCT01006629 · COMPLETED

Trial details

NCT number: NCT01006629
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection Premature Birth Bronchopulmonary Dysplasia Congenital Heart Disease

Start date: 2009-11-01
Primary completion: 2010-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.